Insider trading

Period: 120 months Stock: VIR + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

344 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

344 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

344 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

344 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
344 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
344 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

344 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
24 May 2022
Ramasastry Saira Director
Sold, plan not stated
$40.18K 1,687 at 23.82
17.3%
9 May 2022
SATO VICKI L Director
Sold, plan not stated
$299.84K 14,541 at 20.62
1.0%
28 Apr 2022
SATO VICKI L Director
Sold, plan not stated 2×
$374.42K 17,915 at 20.90
1.2%
30 Mar 2022
HANLY ANN M. Chief Technology Officer
Sold, plan not stated
$68.93K 2,627 at 26.24
3.1%
22 Feb 2022
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$41.25K 1,375 at 30.00
0.8%
18 Feb 2022
SCANGOS GEORGE A President and CEO
Sold, plan not stated
$543.30K 17,726 at 30.65
13.6%
17 Feb 2022
SCANGOS GEORGE A President and CEO
Sold, plan not stated
$320.07K 10,024 at 31.93
7.1%
17 Feb 2022
Pang Phillip Chief Medical Officer
Sold, plan not stated
$96.08K 3,009 at 31.93
3.2%
17 Feb 2022
Sold, plan not stated
$76.41K 2,393 at 31.93
1.2%
17 Feb 2022
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$73.22K 2,293 at 31.93
2.1%
17 Feb 2022
Rice Steven J. Chief Administrative Officer
Sold, plan not stated
$62.01K 1,942 at 31.93
9.4%
16 Feb 2022
Pang Phillip Chief Medical Officer
Sold, plan not stated
$157.70K 5,000 at 31.54
5.1%
8 Feb 2022
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$46.67K 1,375 at 33.94
1.3%
2 Feb 2022
Pang Phillip Chief Medical Officer
Sold, plan not stated
$172.62K 5,000 at 34.52
5.1%
25 Jan 2022
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$44.63K 1,375 at 32.46
1.3%
19 Jan 2022
Pang Phillip Chief Medical Officer
Sold, plan not stated 2×
$175.30K 5,000 at 35.06
5.1%
18 Jan 2022
SATO VICKI L Director
Sold, plan not stated
$567.39K 15,173 at 37.39
1.0%
11 Jan 2022
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$48.26K 1,375 at 35.10
1.3%
5 Jan 2022
Pang Phillip Chief Medical Officer
Sold, plan not stated 2×
$185.96K 5,000 at 37.19
5.1%
28 Dec 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$54.93K 1,375 at 39.95
1.3%
20 Dec 2021
SVF Endurance (Cayman) Ltd 10% owner · indirect
Sold, plan not stated
$21.09M 400,022 at 52.73
1.8%
20 Dec 2021
SATO VICKI L Director
Sold, plan not stated 5×
$827.48K 15,174 at 54.53
1.0%
15 Dec 2021
Pang Phillip Chief Medical Officer
Sold, plan not stated 4×
$253.61K 5,000 at 50.72
5.1%
15 Dec 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$137.50K 2,750 at 50.00
2.5%
14 Dec 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$63.09K 1,375 at 45.88
1.3%
1 Dec 2021
Pang Phillip Chief Medical Officer
Sold, plan not stated 4×
$325.84K 7,500 at 43.45
7.5%
30 Nov 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated 2×
$750.20K 15,125 at 49.60
12.3%
30 Nov 2021
Rice Steven J. Chief Administrative Officer
Sold, plan not stated
$500.00K 10,000 at 50.00
32.7%
30 Nov 2021
Napolitano Janet Director
Sold, plan not stated
$66.37K 1,435 at 46.25
29.8%
29 Nov 2021
HANLY ANN M. Chief Technology Officer · indirect
Bought
$499.85 12 at 43.39
opened
First buy on file
26 Nov 2021
SATO VICKI L Director
Sold, plan not stated
$558.40K 15,174 at 36.80
1.0%
17 Nov 2021
Pang Phillip Chief Medical Officer
Sold, plan not stated 2×
$179.25K 5,000 at 35.85
4.7%
16 Nov 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$44.92K 1,375 at 32.67
1.3%
3 Nov 2021
Pang Phillip Chief Medical Officer
Sold, plan not stated
$182.33K 5,000 at 36.47
4.7%
2 Nov 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$50.79K 1,375 at 36.94
1.3%
20 Oct 2021
Pang Phillip Chief Medical Officer
Sold, plan not stated
$158.60K 4,000 at 39.65
3.8%
19 Oct 2021
SATO VICKI L Director
Sold, plan not stated 2×
$600.31K 15,174 at 39.56
1.0%
19 Oct 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$53.45K 1,375 at 38.87
1.3%
6 Oct 2021
Pang Phillip Chief Medical Officer
Sold, plan not stated
$172.78K 5,000 at 34.56
4.6%
5 Oct 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$46.41K 1,375 at 33.75
1.3%
21 Sep 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$206.25K 4,125 at 50.00
4.0%
17 Sep 2021
SATO VICKI L Director
Sold, plan not stated 2×
$796.30K 15,174 at 52.48
0.9%
15 Sep 2021
Pang Phillip Chief Medical Officer
Sold, plan not stated 2×
$248.46K 5,000 at 49.69
4.6%
7 Sep 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated 2×
$204.88K 4,125 at 49.67
4.0%
1 Sep 2021
Pang Phillip Chief Medical Officer
Sold, plan not stated 3×
$247.88K 5,000 at 49.58
4.4%
30 Aug 2021
Napolitano Janet Director
Sold, plan not stated
$73.40K 1,435 at 51.15
29.8%
25 Aug 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$137.50K 2,750 at 50.00
2.7%
24 Aug 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$66.00K 1,375 at 48.00
1.4%
23 Aug 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$687.50K 13,750 at 50.00
12.1%
23 Aug 2021
Rice Steven J. Chief Administrative Officer
Sold, plan not stated
$500.00K 10,000 at 50.00
33.3%
Showing 201–250 of 344. ← Newer Page 5 of 7 Older →